MedTrace Logo

Berberis Vulgaris Consumption and Blood Pressure

NCT04084847 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2020-10-26

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of barberry consumption on systolic and diastolic blood pressure, serum lipids, and inflammatory status. The study will involve cases having elevated BP (129/ \< 85) and known hypertensive patients on medical treatment. Seventy people will be randomized into two groups, including intervention (barberry) or placebo groups.

Before and after of 8 week intervention, 24-hour ambulatory blood pressure monitoring will be done and fasting venous blood sample will be taken to measure plasma lipids. In addition, 24-hour urine will be collected to measure its sodium content and estimate sodium intake.

Conditions

  • Blood Pressure
  • Cardiovascular Risk Factor
  • Lipid Profile

Interventions

DIETARY_SUPPLEMENT

berberis vulgaris=barberry

10 grams of barberry powder will be consumed daily for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo powder

Sponsors & Collaborators

  • Shahid Beheshti University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-18
Primary Completion
2020-08-19
Completion
2020-10-21

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04084847 on ClinicalTrials.gov